<?xml version="1.0" encoding="UTF-8"?>
<ref id="B91-vaccines-08-00273">
 <label>91.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Overton</surname>
    <given-names>E.T.</given-names>
   </name>
   <name>
    <surname>Lawrence</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Wagner</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Nopora</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>RÃ¶sch</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Young</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Schmidt</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Kreusel</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>De Carli</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>T.P.</given-names>
   </name>
  </person-group>
  <article-title>Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial</article-title>
  <source>PLoS ONE</source>
  <year>2018</year>
  <volume>13</volume>
  <elocation-id>e0195897</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0195897</pub-id>
  <pub-id pub-id-type="pmid">29652929</pub-id>
 </element-citation>
</ref>
